A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies.
about
Effects of curcumin in experimental diabetic nephropathy.Cancer Chemoprevention by Phytochemicals: Nature's Healing Touch."mTOR Signaling Pathway": A Potential Target of Curcumin in the Treatment of Spinal Cord Injury.Styrene maleic acid-encapsulated RL71 micelles suppress tumor growth in a murine xenograft model of triple negative breast cancer.
P2860
A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A liposomal formulation of the ...... future combination therapies.
@en
type
label
A liposomal formulation of the ...... future combination therapies.
@en
prefLabel
A liposomal formulation of the ...... future combination therapies.
@en
P2093
P2860
P1476
A liposomal formulation of the ...... s future combination therapies
@en
P2093
Georg Feldmann
Gerd Bendas
Jens Nolting
Jörg Wenzel
Martin Schlesinger
Peter Brossart
Rolf Schubert
Savita Bisht
Stefan Holdenrieder
P2860
P2888
P356
10.1186/S12951-016-0209-6
P577
2016-07-11T00:00:00Z
P6179
1047445341